Company Filing History:
Years Active: 2025
Title: Innovations of Xinghua Li in Cyclic Peptide Compounds
Introduction
Xinghua Li is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of cyclic peptide compounds, particularly in simulating natural product structures. His innovative work has implications for drug development and molecular biology.
Latest Patents
Xinghua Li holds a patent for a cyclic peptide compound simulating a natural product structure, along with a method for its preparation. The patent describes a method involving a divalent palladium catalyst and a silver salt that undergoes intramolecular arylation in a solvent under heating and stirring. This process constructs a cyclic peptide, generating a compound with diverse arylation sites. The method effectively overcomes previous limitations regarding the types of selectable amino acids, allowing for the construction of a novel aromatic ring-supported cyclic peptide compound. This innovative structure provides a favorable support for the subsequent construction of a cyclic peptide molecular library and high-throughput drug screening.
Career Highlights
Xinghua Li is affiliated with Nankai University, where he continues to advance research in peptide chemistry. His work has garnered attention for its potential applications in pharmaceuticals and biotechnology.
Collaborations
Xinghua Li collaborates with notable colleagues, including Gong Chen and Bo Li, who contribute to his research endeavors.
Conclusion
Xinghua Li's innovative work in cyclic peptide compounds represents a significant advancement in the field of drug development. His contributions are paving the way for new therapeutic possibilities and enhancing our understanding of peptide chemistry.